NeuBase Therapeutics, Inc. announced that on June 26, 2024, Dietrich A. Stephan, Ph.D., Gerald J. McDougall and Eric I. Richman notified the Company of their resignation as a member of the Board, effective immediately. Such resignations did not result from any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3406 EUR | -0.58% |
|
-.--% | -45.94% |
06-27 | NeuBase Therapeutics, Inc. Announces Board Resignations | CI |
05-29 | NeuBase Therapeutics, Inc. announced that it has received $0.000001 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-45.94% | 1.39M | |
+17.29% | 45.34B | |
+42.10% | 40.42B | |
-10.33% | 37.92B | |
+32.53% | 31.75B | |
-8.98% | 27.71B | |
+12.58% | 26.52B | |
+43.86% | 13.96B | |
+31.75% | 12.44B | |
-7.13% | 11.26B |
- Stock Market
- Equities
- O7P Stock
- News NeuBase Therapeutics, Inc.
- NeuBase Therapeutics, Inc. Announces Board Resignations